News Industry News Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers September 15, 2016
News Daily News Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry Michael O'Riordan September 13, 2016
News Daily News Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns Todd Neale September 12, 2016
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Daily News Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities Caitlin E. Cox September 08, 2016
News Daily News Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI Yael L. Maxwell September 02, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Daily News More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds Yael L. Maxwell August 29, 2016
News Daily News Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9 Yael L. Maxwell August 29, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Daily News Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy Michael O'Riordan August 23, 2016
News Daily News Beta-Blockers Not Beneficial After PCI for Stable Angina Michael O'Riordan August 17, 2016
News Daily News Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients Michael O'Riordan August 16, 2016
News Daily News The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say Shelley Wood July 19, 2016
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Statins Lower but Don’t Erase the Excess Risk of Coronary Disease and Death in Familial Hypercholesterolemia Todd Neale July 12, 2016
News Daily News Las Estatinas Minimizan pero No Eliminan el Exceso de Riesgo de Enfermedad Coronaria y Muerte en la Hipercolesterolemia Familiar Todd Neale July 12, 2016